Pharming Group N.V.
PHAR
$13.96
$0.5594.17%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -13.33M | -10.79M | |
| Total Depreciation and Amortization | -- | -- | 10.29M | 13.74M | |
| Total Amortization of Deferred Charges | -- | -- | 884.00K | 884.00K | |
| Total Other Non-Cash Items | -- | -- | 12.67M | -199.00K | |
| Change in Net Operating Assets | -- | -- | -16.28M | -5.80M | |
| Cash from Operations | -- | -- | -5.76M | -2.16M | |
| Capital Expenditure | -- | -- | -745.00K | -1.30M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -24.33M | -127.21M | |
| Cash from Investing | -- | -- | -25.08M | -128.51M | |
| Total Debt Issued | -- | -- | 104.80M | -- | |
| Total Debt Repaid | -- | -- | -137.34M | -3.49M | |
| Issuance of Common Stock | -- | -- | 12.26M | 9.68M | |
| Repurchase of Common Stock | -- | -- | -- | -695.00K | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -6.28M | -6.38M | |
| Cash from Financing | -- | -- | -26.56M | -880.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -488.00K | -1.34M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -57.88M | -132.89M | |